We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rockland Immunochemicals, Inc. CSO Opines “Benefits of Polyclonal Antibodies” in Peer-reviewed Article

News   Aug 10, 2018 | Original story by Rockland Inc

 
Rockland Immunochemicals, Inc. CSO Opines “Benefits of Polyclonal Antibodies” in Peer-reviewed Article
 
 
 

RELATED ARTICLES

Topical Immunotherapy Lowers Risk of Skin Cancer

News

A combination of two topical creams already shown to clear precancerous skin lesions from sun-damaged skin also lowers the risk that patients will later develop squamous cell carcinoma of the skin.

READ MORE

Bacteria Bide Their Time When Antibiotics Attack

News

If an antibiotic doesn’t kill all the bacteria that infects a patient, the surviving bugs may be particularly adept at timing their resurgence.

READ MORE

Tissue-engineering Approach for Common Jaw Defect

News

Cells were taken from the rib cartilage of a Yucatan miniature pig, grown in a laboratory and implanted as a construct into a separate animal.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE